Shanghai Yihao Biotechnology Co., Ltd. is located in Shanghai Juke Biotechnology Park. It is committed to becoming a practitioner in the field of cell therapy in China. It regards “improve innovative tumor immunotherapy” for cancer patients, as a concept, an attitude and a pursuit. It is mainly engaged in the development and application of tumor-specific CAR-T, stem cells and gene editing technology in cancer. The company, founded by the team of the returnees scientists, has the international first-class level GMP cell preparation, molecular biology and cell biology laboratory, and a 1,000 square meter SPF Laboratory Animal Center. At present, the company has established good cooperation with many top-level scientific research institutes and clinics at home and abroad.